About Gene Link
Gene Link is a publicly listed company based in New York (United States) founded in 1993. It operates as a custom oligonucleotides, siRNA, probes, and genetic reagents are supplied. Its website genelink.com draws about 11 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is GENELINK INC. Its competitors include Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Gene Link was founded in 1993 and is based in New York, United States. Operations focus on the biotechnology sector, where custom oligonucleotides, siRNA, fluorescent probes, and genetic tools are provided to researchers. Specialized offerings include Molecular Beacons, TaqMan, and FRET probes, alongside linkers, adaptors, DNA purification kits, and clean-up systems. Reagent systems for detecting genetic disorders are also distributed through the companys product line.
- Headquarters New York, United States
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website genelink.com
- Social LinkedIn
- Legal Name Genelink Inc
- Latest Funding Round$50K (USD), Post-IPO
Apr 2013
Funding Insights of Gene Link
- Total Rounds 6
- Last Round Post-IPO — $50,000
- First Round $1.17M
(Nov 2007)
All 6 funding rounds of Gene Link with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2013 | $50,000 | Post-IPO | – | – | – |
| Oct 2012 | $1.58M | Post-IPO | – | – | – |
| Jan 2011 | $465,000 | Post-IPO | – | – | – |
| Feb 2010 | $150,000 | Post-IPO | – | – | – |
| Jun 2009 | $42,500 | Post-IPO | – | – | – |
| Nov 2007 | $1.17M | Post-IPO | – | – | – |
Timeline of Gene Link
4 dated milestones of Gene Link across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Gene Link is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.2M.
- Funding Latest funding round, Post-IPO, of $50K.
Competitors of Gene Link
Gene Link has 8 listed competitors in our database, 5 of them funded. They include Abcam, Sino Biological, GenScript, Stem Cell Technologies and Miltenyi Biotec, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. |
Detailed competitors of Gene Link
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gene Link
The website of Gene Link (genelink.com) receives about 10.8K visits a month.
- Monthly visits10.8K
▼ 9.9% vs previous month
Websites whose visitors overlap most with Gene Link. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neb.com | 100% | 749.5K | #69,042 | View details | |
| biosearchtech.com | 99% | 52K | #598,672 | View details | |
| biosyn.com | 98% | 41K | #862,186 | View details | |
| trilinkbiotech.com | 96% | 29.9K | #920,436 | View details | |
| biobasic.com | 82% | – | #1,068,685 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 36 similar websites and full traffic analytics for Gene Link
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 36 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Gene Link (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gene Link
Gene Link was founded in 1993 and raised its 1st funding round 14 years after it was founded.
Gene Link is headquartered in New York, United States. It is registered at New York, New York, United States.
Gene Link was founded in 1993 and is based in New York, United States. Operations focus on the biotechnology sector, where custom oligonucleotides, siRNA, fluorescent probes, and genetic tools are provided to researchers. Specialized offerings include Molecular Beacons, TaqMan, and FRET probes, alongside linkers, adaptors, DNA purification kits, and clean-up systems. Reagent systems for detecting genetic disorders are also distributed through the companys product line.
Gene Link's top competitors include Abcam, Sino Biological and Meridian Bioscience.
Gene Link operates through Genelink Inc.